Filing Details

Accession Number:
0001144204-10-009473
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-23 12:00:00
Reporting Period:
2010-02-12
Filing Date:
2010-02-23
Accepted Time:
2010-02-23 15:13:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1137883 Brainstorm Cell Therapeutics Inc BCLI Biological Products, (No Disgnostic Substances) (2836) 912061050
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1318693 David Stolick C/O Brainstorm Cell Therapeutics Inc.
110 East 59Th Street
New York NY 10022
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-02-22 100,000 $0.36 150,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale, and the sales reported on the Form 4 filed on February 19, 2010, were pursuant to a 10b5-1 plan dated October 2009.